McBroom & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
AACR
McBroom & Associates's JNJ Position: Q2 2026 in Review
McBroom & Associates increased its Johnson & Johnson (JNJ) stake by 11% in Q2 2026, buying an estimated $843K and bringing the position to 36,886 shares worth $9.37M. The position accounts for 4.71% of the portfolio, ranked #8.
McBroom & Associates first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- McBroom & Associates held 36,886 shares of Johnson & Johnson worth $9.37M as of Q2 2026.
- McBroom & Associates bought 3,618 Johnson & Johnson shares in Q2 2026, an estimated $843K.
- Johnson & Johnson made up 4.71% of McBroom & Associates's portfolio in Q2 2026, its #8 holding.
- McBroom & Associates first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
- 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on McBroom & Associates's 13F filing for Q2 2026, filed 30 Jul 2026.